The multidisciplinary management of cholangiocarcinoma

被引:14
作者
Ohaegbulam, Kim C. [1 ]
Koethe, Yilun [2 ]
Fung, Alice [3 ]
Mayo, Skye C. [4 ]
Grossberg, Aaron J. [1 ]
Chen, Emerson Y. [5 ]
Sharzehi, Kaveh [6 ]
Kardosh, Adel [5 ]
Farsad, Khashayar [2 ]
Rocha, Flavio G. [4 ]
Thomas, Charles R. [1 ,7 ]
Nabavizadeh, Nima [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Radiat Med, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Dept Intervent Radiol, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Dept Diagnost Radiol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Surg Oncol, Portland, OR 97201 USA
[5] Oregon Hlth & Sci Univ, Div Hematol Med Oncol, Portland, OR 97201 USA
[6] Oregon Hlth & Sci Univ, Div Gastroenterol & Hepatol, Portland, OR 97201 USA
[7] Dartmouth Sch Med, Dept Radiat Oncol, Hanover, NH USA
关键词
biliary disease; cholangiocarcinoma; multidisciplinary; primary liver malignancy; radiotherapy; BILIARY-TRACT CANCER; STEREOTACTIC BODY RADIOTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; CIRCULATING TUMOR-CELLS; DOSE-RATE BRACHYTHERAPY; PRIMARY LIVER CANCERS; INTRAHEPATIC CHOLANGIOCARCINOMA; BILE-DUCT; RADIATION-THERAPY; EXTRAHEPATIC CHOLANGIOCARCINOMA;
D O I
10.1002/cncr.34541
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cholangiocarcinoma is a lethal malignancy of the biliary epithelium that can arise anywhere along the biliary tract. Surgical resection confers the greatest likelihood of long-term survivability. However, its insidious onset, difficult diagnostics, and resultant advanced presentation render the majority of patients unresectable, highlighting the importance of early detection with novel biomarkers. Developing liver-directed therapies and emerging targeted therapeutics may offer improved survivability for patients with unresectable or advanced disease. In this article, the authors review the current multidisciplinary standards of care in resectable and unresectable cholangiocarcinoma, with an emphasis on novel biomarkers for early detection and nonsurgical locoregional therapy options.
引用
收藏
页码:184 / 214
页数:31
相关论文
共 293 条
[1]   Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study [J].
Abou-Alfa, Ghassan K. ;
Macarulla, Teresa ;
Javle, Milind M. ;
Kelley, Robin K. ;
Lubner, Sam J. ;
Adeva, Jorge ;
Cleary, James M. ;
Catenacci, Daniel V. ;
Borad, Mitesh J. ;
Bridgewater, John ;
Harris, William P. ;
Murphy, Adrian G. ;
Oh, Do-Youn ;
Whisenant, Jonathan ;
Lowery, Maeve A. ;
Goyal, Lipika ;
Shroff, Rachna T. ;
El-Khoueiry, Anthony B. ;
Fan, Bin ;
Wu, Bin ;
Chamberlain, Christina X. ;
Jiang, Liewen ;
Gliser, Camelia ;
Pandya, Shuchi S. ;
Valle, Juan W. ;
Zhu, Andrew X. .
LANCET ONCOLOGY, 2020, 21 (06) :796-807
[2]   Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study [J].
Abou-Alfa, Ghassan K. ;
Sahai, Vaibhav ;
Hollebecque, Antoine ;
Vaccaro, Gina ;
Melisi, Davide ;
Al-Rajabi, Raed ;
Paulson, Andrew S. ;
Borad, Mitesh J. ;
Gallinson, David ;
Murphy, Adrian G. ;
Oh, Do-Youn ;
Dotan, Efrat ;
Catenacci, Daniel, V ;
Van Cutsem, Eric ;
Ji, Tao ;
Lihou, Christine F. ;
Zhen, Huiling ;
Feliz, Luis ;
Vogel, Arndt .
LANCET ONCOLOGY, 2020, 21 (05) :671-684
[3]   SELF-EXPANDABLE STAINLESS-STEEL ENDOPROSTHESES FOR TREATMENT OF MALIGNANT BILE-DUCT OBSTRUCTION [J].
ADAM, A ;
CHETTY, N ;
RODDIE, M ;
YEUNG, E ;
BENJAMIN, IS .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1991, 156 (02) :321-325
[4]   Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma [J].
Afonso, Marta B. ;
Rodrigues, Pedro M. ;
Simao, Andre L. ;
Castro, Rui E. .
JOURNAL OF CLINICAL MEDICINE, 2016, 5 (03)
[5]   Principles of and Advances in Percutaneous Ablation [J].
Ahmed, Muneeb ;
Brace, Christopher L. ;
Lee, Fred T., Jr. ;
Goldberg, S. Nahum .
RADIOLOGY, 2011, 258 (02) :351-369
[6]   Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type [J].
Aishima, Shinichi ;
Oda, Yoshinao .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2015, 22 (02) :94-100
[7]   Detection of circulating tumor cells in cancers of biliary origin [J].
Al Ustwani, Omar ;
Iancu, Dan ;
Yacoub, Rabi ;
Iyer, Renuka .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2012, 3 (02) :97-104
[8]   THE IMPACT OF RADIATION-DOSE IN COMBINED EXTERNAL-BEAM AND INTRALUMINAL IR-192 BRACHYTHERAPY FOR BILE-DUCT CANCER [J].
ALDEN, ME ;
MOHIUDDIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (04) :945-951
[9]   Return to Intended Oncologic Treatment (RIOT): A Novel Metric for Evaluating the Quality of Oncosurgical Therapy for Malignancy [J].
Aloia, Thomas A. ;
Zimmitti, Giuseppe ;
Conrad, Claudius ;
Gottumukalla, Vijaya ;
Kopetz, Scott ;
Vauthey, Jean-Nicolas .
JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (02) :107-114
[10]   Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment [J].
Alvaro, Domenico ;
Hassan, Cesare ;
Cardinale, Vincenzo ;
Carpino, Guido ;
Fabris, Luca ;
Gringeri, Enrico ;
Granata, Vincenza ;
Mutignani, Massimiliano ;
Morement, Helen ;
Giuliante, Felice ;
Guglielmi, Alfredo ;
Ridola, Lorenzo ;
Tonini, Giuseppe ;
Marzioni, Marco ;
Grazi, Gianluca ;
Guido, Maria ;
Di Giulio, Emilio ;
Pantano, Francesco ;
Venere, Rosanna ;
Bragazzi, Maria Consiglia ;
Biancanello, Francesca ;
Faccioli, Jessica ;
Giannetti, Aurora ;
Cintolo, Marcello ;
Di Giunta, Michela ;
Gambato, Martina ;
Lasagni, Alberto ;
Izzo, Francesco ;
Avallone, Antonio ;
Banales, Jesus ;
Rossi, Massimo ;
Catalano, Carlo ;
Laghi, Andrea ;
D'Amati, Giulia ;
Mancino, Maria Grazia .
DIGESTIVE AND LIVER DISEASE, 2020, 52 (12) :1430-1442